June 29, 2016
Bausch + Lomb announced the introduction of PreserVision AREDS 2 Formula + Multivitamin. PreserVision combines the AREDS2 study formula with other vitamins and minerals typically found in daily multivitamins.
This 2-in-1 formula is designed to make it simpler for consumers to take their supplements by reducing the number of pills taken each day.
“We are proud to offer consumers greater convenience by providing one supplement that includes the benefits of a daily multivitamin, with the added benefit of the National Eye Institute (NEI) recommended formula from the AREDS2 study found in PreserVisionAREDS 2 Formula,” says Joe Gordon, general manager, Valeant Consumer Healthcare. “We hope that PreserVision AREDS 2 Formula + Multivitamin makes it easier for people to add PreserVision, as recommended by their eyecare professional, to their current regimen of supplements that often includes a daily multivitamin.”
The PreserVision AREDS 2 Formula + Multivitamin is beta carotene-free and contains a high level of Vitamin D, which is designed to support the needs of older adults. The product was created in response to consumer feedback and data, which showed that 90 percent of the participants in the AREDS2 clinical study who took an AREDS supplement also took a daily multivitamin.1 In addition, as we age the use of multivitamin supplements increases, with regular use climbing higher than 50 percent after age 50 and continuing upward to encompass a solid majority of seniors over age 65.2.
The NEI recommends people with moderate-to-advanced age-related macular degeneration (AMD) take a supplement with a specific combination of antioxidants and zinc based on the AREDS2 study.
PreserVision AREDS 2 Formula + Multivitamin is now available in major retailers, including Walgreens, Rite Aid, Kroger and Amazon.
Reference
1. Chew, EY, et al. The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report Number 1). Ophthalmology. 2012 Nov; 119(11): 2282–2289.
2. Results from a Gallup poll, based on telephone interviews conducted Dec. 6-9, 2013, on the Gallup Daily tracking survey, with a random sample of 2,023 adults, aged 18 and older, living in all 50 U.S. states and the District of Columbia.
